Term infant formula supplemented with milk-derived oligosaccharides shifts the gut microbiota closer to that of human milk-fed infants and improves intestinal immune defense: A randomized controlled trial.
Elvira EstorninosRachel B LawenkoEisel PalestroqueNorbert SprengerJalil BenyacoubGuus A M KortmanJos BoekhorstJodi BettlerColin Ivano CercamondiBernard BergerPublished in: The American journal of clinical nutrition (2021)
Infant formula with MOS shifts the gut microbiota and metabolic signature closer to that of HFI, has a strong bifidogenic effect, reduces fecal pathogens, and improves intestinal immune response.